期刊文献+

三阴性乳腺癌的临床病理特征分析 被引量:7

Clinicopathological features of triple-negative breast cancer
原文传递
导出
摘要 目的探讨三阴性乳腺癌(TNBC)的临床病理特征。方法回顾性分析4年间资料完整的3 8例TNBC患者临床资料,包括患者的一般状况、病理特点、分子标志物、复发与转移状况,并与同期非TNBC进行比较。结果≤35岁的患者在TNBC及非TNBC中分别占21.05%(8/38)和5.14%(15/292)(P<0.05)。TNBC组中有淋巴结转移者60.53%(23/38),高于非TNBC的43.49%(127/292)(P<0.05),TNBC组中组织学III级者52.63%(20/38)高于非TNBC组的35.27%(103/292)(P<0.05),TNBC中有瘤周脉管侵犯者占31.58%(12/38)高于非TNBC的15.41%(45/292)(P<0.05)。TNBC组表皮生长因子受体(EGFR)阳性率、血管内皮生长因子(VEGF)阳性率、E-钙黏附蛋白(E-cad)异常表达率分别为81.58%(31/38),78.95%(30/38),65.79%(25/38),高于非TNBC组的39.73%(116/292),61.30%(179/292),48.29%(141/292)(均P<0.05)。远处转移率在TNBC组中分别为2 3.6 8%(9/3 8),非TNBC为1 1.9 9%(3 5/2 9 2),差异有统计学意义(P<0.05)。结论 TNBC较多见于年轻患者,浸润转移率高,预后不良。 Objective To identify the elinieopathological features of triple-negative breast cancer (TNBC). Methods There were 38 TNBC patients with complete records available who were admitted to our hospital over a 4- year period. Their clinical data that included the general conditions, pathological features, molecular markers, recurrence and metastasis were retrospectively analyzed and were compared with those of non-TNBC patients admitted during the same period. Results In the TNBC and non-TNBC patients, the cases less than 35 years old accounted for 21.05% and 5. 14% , respectively (P 〈 0.05 ). The patients with lymph nodes metastases accounted for 60.53% (23/38) of the TNBC patients, which was higher than that of the uou-TNBC patients (43.49%, 127/292) (P 〈 0.05 ). Tumors of histological grade III were found in 52. 63% (20/38) of the TNBC patients, which was higher than that of the non-TNBC patients (35.27% , 103/292) (P 〈0.05). Peritumoral vascular invasion occurred in 31. 58% (12/38) of TNBC patients, which was higher than that of the non-TNBC patients ( 15.41% , 45/292 ) ( P 〈 0.05 ). The positive rate of epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) , and the abnormal expression rate of E-cadherin were 81.58% (31/38) , 78.95% (30/38) and 65.79% (25/38), respectively, in the TNBC patients, all which were higher than those in the non-TNBC patients ~39.73% (116/292) , 61. 30% (179/292) and 48. 29% (141/292) ] (all P〈0.05). The distant metastasis rate was 23. 68% (9/38) in the TNBC patients and 11. 99% ( 35/292 ) in the uon-TNl^C patients, respectively, and that was statistically different ( P 〈 0. 05 ). Conclusions TNBC usually occurs in young people, and has a higher metastasis rate and poor prognosis.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2011年第11期1196-1198,共3页 China Journal of General Surgery
关键词 乳腺肿瘤/病理学 三阴性乳腺癌 分子标志物 预后 Breast Neoplasms/pathol Triple-negative Breast Cancer Molecular Marker Prognosis
  • 相关文献

参考文献11

  • 1Kim M J, Ro JY, Ahn SH, et al. Clinicopathologic significance of the basal-like subtype of breast cancer : a comparison with hormone z~ceptor and Her2/neu-overexpressing phenotypes[J]. Hum Pathol, 2006, 37 (9): 1217 - 1226.
  • 2Sasa M, Bando Y, Takahashi marker expression is necessary egy for triple-negative breast 2008, 97(1) :30 -34. M, et al. Screening for basal for decision of therapeutic', stratcancer [ J ]. J Surg Oneol,.
  • 3Bauer KR, Brown M, Cress RD, et al. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor ( PR ) - negative, and HER2 - negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study fi'om the California cancer Registry [ J ]. Cancer, 2007, 109(9) :1721 -1728.
  • 4Trivers KF, Lund M J, Porter PL, et al. The epidemiology of triplenegative breast cancer, including race [ J ] . Cancer Causes Control, 2009, 20(7) :1071 - !082.
  • 5Vona-Davis L, Rose DP, Hazard H, et al. Triple-negative breast cancer and obesity in a rural Appalachian population [ J ]. Cancer Epidemiol Biomaarkers Prey, 2008, 17 (12) :3319 -3324.
  • 6Kandel MJ, Stadler Z, Masciari S, et al. Prevalence of BRCAI mutations in triple negative breast cancer (BC) [J]. J Clin Oncol (Meeting Abstracts) , 2006, 24( 18 Suppl) :508.
  • 7Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence [J]. Clin Cancer Res, 2007, 13 ( 15 pt I ) :4429 - 4434.
  • 8Siziopikou KP, Cobleigh M. The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR - targeted therapies [ J ] . Breast, 2 0 0 7 , 16(1) :104 - 107.
  • 9Mahler-Araujo B, Savage K, Parry S, et al. Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal - like and triple negative phenotype [ J ] . J Clin Pathol, 2008, 61 (5) :615 -620.
  • 10Rakha EA, E1-Sayed ME, Green AR, et al. Prognostic markers in tripple negative breast cancer [ J ]. Cancer, 2007,109(1 ) :25 -32.

同被引文献158

引证文献7

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部